<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04440722</url>
  </required_header>
  <id_info>
    <org_study_id>BICTX02</org_study_id>
    <nct_id>NCT04440722</nct_id>
  </id_info>
  <brief_title>Prospective Observational Study and Biobank CKIO</brief_title>
  <official_title>Prospective Observational Study and Biobank in All Persons Referred to Center of Gender Identity Odense University Hospital (CKIO)/Body Identity Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective observational study and biobank in all persons referred to CKIO&#xD;
&#xD;
        -  Patient involvement and quality of life&#xD;
&#xD;
        -  Population characteristics regarding hormone levels, safety parameters and clinical&#xD;
           outcome before and after gender affirming hormone treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective observational cohort study including all patients referred to the&#xD;
      Center of Gender Identity Odense. The purpose is to follow patients yearly to observe patient&#xD;
      reported outcomes and control the quality and effects of the clinical treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2040</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2040</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient reported outcomes (PRO)</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Questionnaires</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hormone levels</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Blood samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety parameters</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Blood samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Blood pressure measured in a sitting position</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Body mass index calculated from height an weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Body weight measured on a scale in kilogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hair cortisol</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Hair samples 3 mm thick from the back of the head</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol metabolism</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>24 hour urine samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry</measure>
    <time_frame>Every 52 weeks</time_frame>
    <description>Forced vital capacity is measured by a spirometer</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Transgender</condition>
  <arm_group>
    <arm_group_label>Transgender individuals</arm_group_label>
    <description>All transgender individuals referred to center of gender identity Odense</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, urine, hair&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients referred til CKIO&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All Individuals with gender dysforia who are referred to Center of Gender Identity&#xD;
             Odense&#xD;
&#xD;
          -  Age 18+&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Â°There are no exclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marianne Andersen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dorte Glintborg, Dr med</last_name>
    <phone>65412502</phone>
    <phone_ext>45</phone_ext>
    <email>dorte.glintborg@rsyd.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Endocrinology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorte Glintborg, MD PhD</last_name>
      <phone>0045 65412502</phone>
      <email>dorte.glintborg@rsyd.dk</email>
    </contact>
    <investigator>
      <last_name>Marianne Andersen, DMSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 11, 2020</study_first_submitted>
  <study_first_submitted_qc>June 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2020</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Marianne Andersen</investigator_full_name>
    <investigator_title>Consultat, Dr Med, professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

